1. SGA has brought 2-4 years of investment uncertainty to CRY. So don't expect too much in the way of stock performance for a while. Let's say get ready for more of the same.http://finance.yahoo.com/q/bc?s=CRY&t=2y&l=off&z=l&q=l&c=^GSPChttp://finance.yahoo.com/q/bc?s=CRY&t=my&l=off&z=l&q=l&c=^GSPC2. I don't see CRY going to the moon any time soon. The legal issues are complex and likely to go to trial, I'm guessing 2-3 years from now, so prepare to wait for your CRY stock to appreciate. 3. Medafor will not be delivering any more HemoStase to CRY. Game over.4. The analyst estimates for 2011 are now too high.Thank SGA for the uncertainty.
What about the news on japan?Bio glue being approved.
I don't know about BioGlue being approved in Japan. They still need to sell it, which means they need a good distributor...which they may have, I don't know. But what took them this long? I assume the delay is another great job done by SGA.